Drug profile

The FDA adverse-event record for Lincomycin Hydrochloride

45 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Lincomycin Hydrochloride. Species, reactions, and outcomes follow.

#1187 of 2,679
by report volume (all drugs)
45
adverse-event reports
13.3%
death-coded share
Pig
most-reported species
Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Lincomycin Hydrochloride ranks #1182 of 2679 by total reports (45). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#1182
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Lincomycin Hydrochloride has 45 reports now versus 45 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Lincomycin Hydrochloride changes

Signature read: death-coded share at 13.3% is the most distinctive stamp on Lincomycin Hydrochloride's FDA AER row.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
45
Total Reports
6
Deaths Reported
13.3%
Death-coded share of reports

Active Ingredients

Lincomycin Hydrochloride

Administration Routes

UnknownOralIntramuscularSubcutaneousTopicalParenteral

Species Affected

Pig 16
Unknown 13
Dog 9
Cat 3
Human 3
Cattle 1

Most Affected Breeds

Unknown 16
Crossbred Porcine/Pig 11
Pig (unknown) 4
Spaniel - Cocker American 2
Retriever - Labrador 2
Terrier - Boston 1
Domestic (unspecified) 1
Pit Bull 1
Chow Chow 1
Retriever - Chesapeake Bay 1

Most Reported Reactions

Lack of efficacy (bacteria) - NOS 10
Diarrhoea 5
Product Defect, General 3
Increased mortality rate 3
No sign 2
Pruritus 2
Vomiting 2
Containers, Damaged 2
Urticaria 2
Depression 2
Death 2
Underfilling, Bottles 2

Outcome Breakdown

Outcome Unknown
13 (50.0%)
Died
6 (23.1%)
Recovered/Normal
4 (15.4%)
Ongoing
3 (11.5%)

Lincomycin Hydrochloride Adverse Event Insights

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Lincomycin Hydrochloride (#1187 of 2,679 by report volume); death-coded 13.3%. PlainBreed drug row · death-coded share stamp 13.3% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →